Status:
RECRUITING
Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
Lead Sponsor:
The Cleveland Clinic
Conditions:
Uveitis
Eligibility:
All Genders
18+ years
Brief Summary
We will prospectively observe patients with uveitis who are either active or were recently active in the previous 6 months and are treated with the i-FA implant. All of the patients will have standard...
Detailed Description
Prospective imaging of the intrAvitreal fluocinoloNe acetonide implant using fluorescein angiography and opTical coHerencE tomogRaphy in uveitis patients. (PANTHER) Background Uveitis, a disease with...
Eligibility Criteria
Inclusion
- 1\. Any patient with a diagnosis of uveitis, who is deemed active or recently active (6 months) by a uveitis specialist and requires an injectable fluocinolone acetonide implant to treat their inflammation.
Exclusion
- \- 1. Poor view in fundus in both eyes which precludes image acquisition in those with posterior uveitis 2. Those with any allergy to fluorescein 3. Corneal opacities which prevent image acquisition 4. Inability to sign consent 5. Poor candidates for injectable fluocinolone acetonide (advanced glaucoma without previous filtering surgery, chronic elevated IOP (\>25) on maximal topical anti-glaucoma drops and evidence of optic nerve progression.
- 6\. Children under the age of 18 and pregnant/nursing mothers.
Key Trial Info
Start Date :
August 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04340505
Start Date
August 8 2019
End Date
March 1 2026
Last Update
February 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cole Eye Institute Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195